• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

Takeda Pharmaceutical Co Ltd

+ Add to Watchlist


34.445 EUR 0.185 0.53%

As of 05:46:26 ET on 09/16/2014.

Snapshot for Takeda Pharmaceutical Co Ltd (TKD)

Open: 34.425 Day's Range: 34.425 - 34.740 Volume: 220
Previous Close: 34.630 52wk Range: 30.975 - 36.600 1-Yr Rtn: +1.23%

Stock Chart for TKD

No chart data available.
  • TKD:GR 34.445
  • 1D
  • 1M
  • 1Y
Interactive TKD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TKD

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) 27.6704
Relative P/E vs. DAX -
Earnings Per Share (JPY) (ttm) -
Est. EPS (JPY) (03/2015) 173.9730
Est. PEG Ratio 2.1351
Market Cap (M EUR) 27,414.99
Shares Outstanding (M) 789.72
30 Day Average Volume 226
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 3.73%
Cash Dividend (JPY) 90.0000
Dividend Ex-Date 09/26/2014
5 Year Dividend Growth 0.93%
Next Earnings Announcement 10/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TKD

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for TKD

Takeda Pharmaceutical Company Limited mainly manufactures and sells pharmaceuticals, food supplements, and chemical products like polyurethane. The Company also produces food, agrochemicals, and environment-related products such as pollution detectors. Takeda Pharmaceutical researches, develops, and promotes the products through its related companies in the US, Europe, and Asia.

Yasuchika HasegawaChairmanChristophe WeberPresident/CEO
Shinji HondaSenior Managing DirectorYasuhiko YamanakaManaging Director
More Company Profile & Key Executives for TKD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil